| |
| |
|
| Insider
Information: |
Bradbury Daniel |
| Relationship: |
Director |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
8 |
|
| Direct
Shares |
232,105 |
|
|
Indirect Shares
|
3,171,910 |
|
|
| Direct
Value |
$2,992,474 |
|
|
|
Indirect Value
|
$5,751,385 |
|
|
| Total
Shares |
3,404,015 |
|
|
| Total
Value |
$8,743,859 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Amylin Pharmaceuticals Inc |
AMLN |
President & Chief Exec... |
2012-08-08 |
0 |
2012-08-08 |
0 |
Premium* |
|
|
Paratek Pharmaceuticals Inc |
PRTK |
Director |
2006-05-09 |
35,714 |
|
0 |
Premium* |
|
|
Illumina Inc |
ILMN |
Director |
2017-05-25 |
15,324 |
2008-05-16 |
0 |
Premium* |
|
|
Corcept Therapeutics Inc |
CORT |
Director |
2012-11-21 |
0 |
2019-02-07 |
130,575 |
Premium* |
|
|
Geron Corporation |
GERN |
Director |
2014-05-09 |
142,776 |
2019-03-29 |
51,323 |
Premium* |
|
|
Equillium Inc |
EQ |
Chief Executive Office... |
2018-10-16 |
0 |
2018-10-16 |
2,969,596 |
Premium* |
|
|
Castle Biosciences Inc |
CSTL |
Director |
2024-05-25 |
13,291 |
2024-09-05 |
20,416 |
Premium* |
|
|
Nuvation Bio Ord Shs Class A |
NUVB |
Director |
2021-02-10 |
25,000 |
2021-02-10 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
426 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 5 of 18
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ILMN |
Illumina Inc |
Director |
– • – |
2010-03-02 |
4 |
OE |
$3.24 |
$16,440 |
D/D |
3,600 |
3,737 |
0 |
- |
|
| ILMN |
Illumina Inc |
Director |
– • – |
2012-07-03 |
4 |
A |
$44.95 |
$18,744 |
D/D |
417 |
7,490 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Chief Operating Officer |
• – – |
2004-10-07 |
4 |
AS |
$20.75 |
$20,750 |
I/I |
(1,000) |
14,691 |
|
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Chief Operating Officer |
• – – |
2004-09-08 |
4 |
AS |
$20.97 |
$20,985 |
I/I |
(1,000) |
15,691 |
|
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Chief Operating Officer |
• – – |
2004-12-07 |
4 |
AS |
$21.45 |
$21,475 |
I/I |
(1,000) |
12,581 |
|
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Chief Operating Officer |
• – – |
2005-01-05 |
4 |
AS |
$22.66 |
$22,660 |
I/I |
(1,000) |
9,581 |
|
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Chief Operating Officer |
• – – |
2004-11-05 |
4 |
AS |
$23.15 |
$23,150 |
I/I |
(1,000) |
13,581 |
|
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2023-12-13 |
4 |
AS |
$20.04 |
$23,407 |
I/I |
(1,168) |
49,816 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2023-12-12 |
4 |
AS |
$20.01 |
$24,012 |
I/I |
(1,200) |
50,215 |
0 |
- |
|
| ILMN |
Illumina Inc |
Director |
– • – |
2008-06-18 |
4 |
OE |
$8.07 |
$24,210 |
D/D |
3,000 |
4,000 |
0 |
- |
|
| ILMN |
Illumina Inc |
Director |
– • – |
2008-07-23 |
4 |
OE |
$8.07 |
$24,210 |
D/D |
3,000 |
4,000 |
0 |
- |
|
| ILMN |
Illumina Inc |
Director |
– • – |
2008-08-19 |
4 |
OE |
$8.07 |
$24,210 |
D/D |
3,000 |
1,400 |
0 |
- |
|
| ILMN |
Illumina Inc |
Director |
– • – |
2008-10-21 |
4 |
OE |
$4.04 |
$24,210 |
D/D |
6,000 |
2,500 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Director |
– • – |
2014-05-12 |
4 |
B |
$1.83 |
$25,522 |
I/I |
13,925 |
317,925 |
2.1 |
- |
|
| ILMN |
Illumina Inc |
Director |
– • – |
2010-08-10 |
4 |
OE |
$4.04 |
$25,824 |
D/D |
6,400 |
2,037 |
0 |
- |
|
| ILMN |
Illumina Inc |
Director |
– • – |
2010-09-10 |
4 |
OE |
$4.04 |
$25,824 |
D/D |
6,400 |
2,637 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
President & Chief Executive Of |
• – – |
2012-03-01 |
4 |
S |
$17.11 |
$26,332 |
D/D |
(1,539) |
62,912 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Chief Operating Officer |
• – – |
2005-07-07 |
4 |
AS |
$20.50 |
$30,750 |
I/I |
(1,500) |
6,481 |
|
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Chief Operating Officer |
• – – |
2006-01-31 |
4 |
A |
$19.46 |
$30,827 |
D/D |
1,332 |
28,600 |
|
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Chief Operating Officer |
• – – |
2005-02-07 |
4 |
AS |
$23.00 |
$34,500 |
I/I |
(1,500) |
8,081 |
|
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2023-09-01 |
4 |
AS |
$20.04 |
$36,112 |
I/I |
(1,802) |
65,062 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2021-08-17 |
4 |
AS |
$60.00 |
$38,653 |
I/I |
(644) |
150,143 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Chief Operating Officer |
• – – |
2005-08-05 |
4 |
AS |
$20.01 |
$40,020 |
I/I |
(2,000) |
4,481 |
|
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Chief Operating Officer |
• – – |
2006-03-07 |
4/A |
AS |
$42.50 |
$42,500 |
D/D |
(1,000) |
23,600 |
|
- |
|
| ILMN |
Illumina Inc |
Director |
• • – |
2016-08-17 |
4 |
OE |
$71.09 |
$42,654 |
D/D |
600 |
17,065 |
0 |
- |
|
426 Records found
|
|
Page 5 of 18 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
